Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Big Pharma, Little Science? A bibliometric perspective on big pharma&apos, s R&amp, D decline

  • Ismael Rafols
  • Hopkins, M.M.
  • Hoekman, J.
  • Siepel, J.
  • O'Hare, A.
  • Perianes-Rodriguez, A.
  • Nightingale, P.
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical R&D dynamics by examining the publication activities of all R&D laboratories of the major European and US pharmaceutical firms (Big Pharma) during the period 1995-2009. The empirical findings present an industry in transformation. In the first place, we observe a decline of the total number of publications by large firms. Second, we show a relative increase of their external collaborations suggesting a tendency to outsource, and a diversification of the disciplinary base, in particular towards computation, health services and more clinical approaches. Also evident is a more pronounced decline in publications by both R&D laboratories located in Europe and by firms with European headquarters. Finally, while publications by Big Pharma in emerging economies sharply increase, they remain extremely low compared with those in developed countries. In summary, the trend in this transformation is one of a gradual decrease in internal research efforts and increasing reliance on external research. These empirical insights support the view that Big Pharma are increasingly becoming 'network integrators' rather than the prime locus of drug discovery., We thank Mike O'Neill, Luigi Orsenigo and Sergio Sismondo for comments. Ismael Rafols and Alice O'Hare were funded by the EU FP7 project FRIDA(Grant 225546, http://www.fridaproject.eu) and the US NSF (Award no. 0830207, http://idr.gatech.edu/). Michael Hopkins and Josh Siepel were supported by ESRC grant RES-360-25-0076. Jarno Hoekman has been supported by the Netherlands Organisation for Scientific Research (NWO) under the VIDI programme, number 452-06-005. Antonio Perianes-Rodríguez conducted his research at the University of Sussex as awardee of José Castillejo grant, JC2010-0042, funded by the Spanish Ministry of Education. The findings and observations contained in this paper are those of the authors and do not necessarily reflect the views of the funders.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Bibliometric perspectives on medical innovation using the medical subject Headings of Pubmed

  • Leydesdorff, L.
  • Rotolo, D.
  • Rafols García, Ismael
Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the MEDLINE database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspective on the dynamics of medical innovations. To this end, we first analyze the MEDLINE database, the MeSH index tree, and the various options for a static mapping from different perspectives and at different levels of aggregation. Following a specific innovation (RNA interference) over time, the notion of a trajectory which leaves a signature in the database is elaborated. Can the detailed index terms describing the dynamics of research be used to predict the diffusion dynamics of research results? Possibilities are specified for further integration between the MEDLINE database on one hand, and the Science Citation Index and Scopus (containing citation information) on the other. © 2012 ASIS&T., We acknowledge support by the ESRC project "Mapping the Dynamics of Emergent Technologies" (RES-360-25-0076). Ismael Rafols acknowledges funding from U.S. National Science Foundation (Award 0830207, "Measuring and Tracking Research Knowledge Integration"). The findings and observations contained in this article are those of the authors and do not necessarily reflect the views of the funding agencies. We are grateful to Lutz Bornmann and Tobias Opthof for comments on previous drafts.